Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: Dexmedetomidine Sublingual Film for the Ambulatory Treatment of Hyperadrenergic Autonomic Crisis in Patients With Familial Dysautonomia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating a dexmedetomidine sublingual film for ambulatory treatment of hyperadrenergic autonomic crises in patients with Familial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine Sublingual Film (dexmedetomidine)

Snippet

Sponsor: NYU Langone Health | Conditions: Familial Dysautonomia | Phase 2 | Status: ENROLLING_BY_INVITATION